This yearlong study will test adult volunteers for antibodies in their blood that indicate exposure to SARS-CoV-2, the virus that causes COVID-19. Researchers hope to learn more about disease symptoms and how many antibodies stay in a person’s blood over the course of a year. This information will help inform public health efforts in the future.
A team, led by Dr. Stavros Garantziotis, M.D., at the National Institute of Environmental Health Sciences (NIEHS) Clinical Research Unit in Research Triangle Park, North Carolina.
Stavros Garantziotis, M.D. is passionate about finding cures for chronic lung disease like asthma, COPD and pulmonary fibrosis. He believes that if we can understand the mechanism of disease development for every individual patient, we can design intelligent and effective treatment with less side effects. Dr. Garantziotis obtained his medical degree at the Albert-Ludwigs-University in Germany. He trained in Internal Medicine at the Albert Einstein College of Medicine in New York and in Pulmonary and Critical Care Medicine at Duke University Medical Center, where he was a faculty member before joining the NIEHS to direct the Clinical Research Unit.
This content is available to use on your website.Please visit NIEHS Syndication to get started.